Work

The effectiveness od early time restricted feeding as a lifestyle medicine intervention on control metabolic syndrome (dyslipidemia and hypertension in our case study)

Year: 2025
Type: dissertation
Study design: Case Report
Abstract: Introduction:This postgraduate thesis explores the effects of Early Time-Restricted Feeding (eTRF) on a 59-year-old female patient diagnosed with hypertension, hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), and fibromyalgia.Over a 7month nutritional intervention, significant improvements were recorded in blood pressure, lipid profile, body mass ndex (BMI), inflammatory markers, liver enzymes, and insulin resistance (HOMA-IR), without medication changes except for a halved antihypertensive dose during the second trimester.The protocol also included recommendations to walk at least 9,000 steps per day and practice structured stress management (e.g., breathing exercises,mindfulness, and contact with nature and loved ones).The case supports eTRF as a promising non-pharmacological strategy for managing metabolic andcardiovascular risk factors.Early Time-Restricted Feeding (eTRF) is a form of intermittent fasting that limits daily food intake to the earlier part of the day,aligning with the body's circadian rhythm.Recent studies suggest it may improve metabolic health, reduce cardiovascular risk, and enhance insulin sensitivity.Despite promising evidence, real-world case applications in patients with multiple comorbidities remain limited.Aims:This study aimed to investigate the effectiveness of eTRF, in combination with light physical activity and stress management, in improving metabolic parameters in a 59-year-old woman diagnosed with hypertension, hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), and fibromyalgia.Methodology: Over a 7-month period, the patient followed an eating window from 08:00 to 14:00, walked at least 9,000 steps daily, and practiced stress-reduction techniques such as diaphragmatic breathing,mindfulness, and regular exposure to nature.No caloric restriction or structured exercise was imposed.Monthly assessments included blood pressure, body mass index (BMI), fasting glucose and insulin, HOMA-IR, lipid profile, liver enzymes, and nflammatory markers.Antihypertensive medication (Codiovan 160 mg) was halved in the second trimester.Results: Substantial improvements were observed.Blood pressure declined from 136/82 to 115/71 mmHg.Weight reduced from 62.5 kg to 53.5 kg, and BMI from 26.7 to 22.9.HOMA-IR improved from 2.11 to 0.74.LDL cholesterol dropped from 146 to 111 mg/dL, triglycerides from 163 to95 mg/dL, and HDL increased from 57 to 63 mg/dL.Liver enzymes and hshowed marked reductions.Conclusion: This case highlights the potential of eTRF as a non-pharmacological intervention to manage metabolic disorders.Even with partial adherence during one trimester, benefits were sustained.The synergy of eTRF with physical activity and stress management enhance metabolic resilience, offering a promising strategy for long-term lifestyle intervention
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7124120701
Cites: 13
Cited by:
Related to: 10